Enrofloxacin Permeation Pathways across the Porin OmpC. 2018

Jigneshkumar Dahyabhai Prajapati, and Carlos José Fernández Solano, and Mathias Winterhalter, and Ulrich Kleinekathöfer
Department of Physics and Earth Sciences and ‡Department of Life Sciences and Chemistry, Jacobs University Bremen , 28759 Bremen, Germany.

In Gram-negative bacteria, the lack or quenching of antibiotic translocation across the outer membrane is one of the main factors for acquiring antibiotic resistance. An atomic-level comprehension of the key features governing the transport of drugs by outer-membrane protein channels would be very helpful in developing the next generation of antibiotics. In a previous study [ J. D. Prajapati et al. J. Chem. Theory Comput. 2017 , 13 , 4553 ], we characterized the diffusion pathway of a ciprofloxacin molecule through the outer membrane porin OmpC of Escherichia coli by combining metadynamics and a zero-temperature string method. Here, we evaluate the diffusion route through the OmpC porin for a similar fluoroquinolone, that is, the enrofloxacin molecule, using the previously developed protocol. As a result, it was found that the lowest-energy pathway was similar to that for ciprofloxacin; namely, a reorientation was required on the extracellular side with the carboxyl group ahead before enrofloxacin reached the constriction region. In turn, the free-energy basins for both antibiotics are located at similar positions in the space defined by selected reaction coordinates, and their affinity sites share a wide number of porin residues. However, there are some important deviations due to the chemical differences of these two drugs. On the one hand, a slower diffusion process is expected for enrofloxacin, as the permeation pathway exhibits higher overall energy barriers, mainly in the constriction region. On the other hand, enrofloxacin needs to replace some polar interactions in its affinity sites with nonpolar ones. This study demonstrates how minor chemical modifications can qualitatively affect the translocation mechanism of an antibiotic molecule.

UI MeSH Term Description Entries
D004926 Escherichia coli A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc. Alkalescens-Dispar Group,Bacillus coli,Bacterium coli,Bacterium coli commune,Diffusely Adherent Escherichia coli,E coli,EAggEC,Enteroaggregative Escherichia coli,Enterococcus coli,Diffusely Adherent E. coli,Enteroaggregative E. coli,Enteroinvasive E. coli,Enteroinvasive Escherichia coli
D000077422 Enrofloxacin A fluoroquinolone antibacterial and antimycoplasma agent that is used in veterinary practice. Bay Vp 2674,Bay-Vp-2674,Baytril,Endrofloxicin
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D056004 Molecular Dynamics Simulation A computer simulation developed to study the motion of molecules over a period of time. Molecular Dynamics Simulations,Molecular Dynamics,Dynamic, Molecular,Dynamics Simulation, Molecular,Dynamics Simulations, Molecular,Dynamics, Molecular,Molecular Dynamic,Simulation, Molecular Dynamics,Simulations, Molecular Dynamics
D018272 Porins Porins are protein molecules that were originally found in the outer membrane of GRAM-NEGATIVE BACTERIA and that form multi-meric channels for the passive DIFFUSION of WATER; IONS; or other small molecules. Porins are present in bacterial CELL WALLS, as well as in plant, fungal, mammalian and other vertebrate CELL MEMBRANES and MITOCHONDRIAL MEMBRANES. Pore Protein,Pore Proteins,Porin,Protein, Pore,Proteins, Pore
D024841 Fluoroquinolones A group of QUINOLONES with at least one fluorine atom and a piperazinyl group. Fluoroquinolone

Related Publications

Jigneshkumar Dahyabhai Prajapati, and Carlos José Fernández Solano, and Mathias Winterhalter, and Ulrich Kleinekathöfer
December 1982, Antimicrobial agents and chemotherapy,
Jigneshkumar Dahyabhai Prajapati, and Carlos José Fernández Solano, and Mathias Winterhalter, and Ulrich Kleinekathöfer
December 1995, Infection and immunity,
Jigneshkumar Dahyabhai Prajapati, and Carlos José Fernández Solano, and Mathias Winterhalter, and Ulrich Kleinekathöfer
February 1996, FEBS letters,
Jigneshkumar Dahyabhai Prajapati, and Carlos José Fernández Solano, and Mathias Winterhalter, and Ulrich Kleinekathöfer
August 1988, Nucleic acids research,
Jigneshkumar Dahyabhai Prajapati, and Carlos José Fernández Solano, and Mathias Winterhalter, and Ulrich Kleinekathöfer
August 1999, Canadian journal of microbiology,
Jigneshkumar Dahyabhai Prajapati, and Carlos José Fernández Solano, and Mathias Winterhalter, and Ulrich Kleinekathöfer
September 1992, Journal of general microbiology,
Jigneshkumar Dahyabhai Prajapati, and Carlos José Fernández Solano, and Mathias Winterhalter, and Ulrich Kleinekathöfer
March 2005, Protein expression and purification,
Jigneshkumar Dahyabhai Prajapati, and Carlos José Fernández Solano, and Mathias Winterhalter, and Ulrich Kleinekathöfer
April 1999, FEMS microbiology letters,
Jigneshkumar Dahyabhai Prajapati, and Carlos José Fernández Solano, and Mathias Winterhalter, and Ulrich Kleinekathöfer
January 2019, Frontiers in immunology,
Jigneshkumar Dahyabhai Prajapati, and Carlos José Fernández Solano, and Mathias Winterhalter, and Ulrich Kleinekathöfer
January 2019, Biophysical journal,
Copied contents to your clipboard!